(Reuters) - Analysts, on average, were expecting Teva to earn $2.11 on a GAAP basis and $2.12 before items, according to Reuters Estimates.
Read more at Reuters.com Market News
Subscribe to:
Post Comments (Atom)
The Longs and the Shorts of my trading on the JSE. My thoughts, actions and rambelings while trading. The thing I love best!
No comments:
Post a Comment